Cargando…

How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19?()

Detalles Bibliográficos
Autores principales: Wei, Wei, Jiang, Hao, Chen, Weipeng, Zhou, Yuling, Guo, Shuanshuan, Zhong, Guihua, Zhou, Huaili, Wang, Siyang, Zhang, Hongyu, Jiang, Wen, Liu, Zhi-gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156132/
https://www.ncbi.nlm.nih.gov/pubmed/32259751
http://dx.doi.org/10.1016/j.radonc.2020.03.016
_version_ 1783522156572835840
author Wei, Wei
Jiang, Hao
Chen, Weipeng
Zhou, Yuling
Guo, Shuanshuan
Zhong, Guihua
Zhou, Huaili
Wang, Siyang
Zhang, Hongyu
Jiang, Wen
Liu, Zhi-gang
author_facet Wei, Wei
Jiang, Hao
Chen, Weipeng
Zhou, Yuling
Guo, Shuanshuan
Zhong, Guihua
Zhou, Huaili
Wang, Siyang
Zhang, Hongyu
Jiang, Wen
Liu, Zhi-gang
author_sort Wei, Wei
collection PubMed
description
format Online
Article
Text
id pubmed-7156132
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71561322020-04-15 How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19?() Wei, Wei Jiang, Hao Chen, Weipeng Zhou, Yuling Guo, Shuanshuan Zhong, Guihua Zhou, Huaili Wang, Siyang Zhang, Hongyu Jiang, Wen Liu, Zhi-gang Radiother Oncol Article Elsevier B.V. 2020-06 2020-03-27 /pmc/articles/PMC7156132/ /pubmed/32259751 http://dx.doi.org/10.1016/j.radonc.2020.03.016 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Wei, Wei
Jiang, Hao
Chen, Weipeng
Zhou, Yuling
Guo, Shuanshuan
Zhong, Guihua
Zhou, Huaili
Wang, Siyang
Zhang, Hongyu
Jiang, Wen
Liu, Zhi-gang
How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19?()
title How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19?()
title_full How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19?()
title_fullStr How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19?()
title_full_unstemmed How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19?()
title_short How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19?()
title_sort how should we implement radiotherapy for cancer patients in china during the endemic period of covid-19?()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156132/
https://www.ncbi.nlm.nih.gov/pubmed/32259751
http://dx.doi.org/10.1016/j.radonc.2020.03.016
work_keys_str_mv AT weiwei howshouldweimplementradiotherapyforcancerpatientsinchinaduringtheendemicperiodofcovid19
AT jianghao howshouldweimplementradiotherapyforcancerpatientsinchinaduringtheendemicperiodofcovid19
AT chenweipeng howshouldweimplementradiotherapyforcancerpatientsinchinaduringtheendemicperiodofcovid19
AT zhouyuling howshouldweimplementradiotherapyforcancerpatientsinchinaduringtheendemicperiodofcovid19
AT guoshuanshuan howshouldweimplementradiotherapyforcancerpatientsinchinaduringtheendemicperiodofcovid19
AT zhongguihua howshouldweimplementradiotherapyforcancerpatientsinchinaduringtheendemicperiodofcovid19
AT zhouhuaili howshouldweimplementradiotherapyforcancerpatientsinchinaduringtheendemicperiodofcovid19
AT wangsiyang howshouldweimplementradiotherapyforcancerpatientsinchinaduringtheendemicperiodofcovid19
AT zhanghongyu howshouldweimplementradiotherapyforcancerpatientsinchinaduringtheendemicperiodofcovid19
AT jiangwen howshouldweimplementradiotherapyforcancerpatientsinchinaduringtheendemicperiodofcovid19
AT liuzhigang howshouldweimplementradiotherapyforcancerpatientsinchinaduringtheendemicperiodofcovid19